Internal Medicine, Pulmonary Disease · Portland, OR
NPI
1285731059
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
4
Hospital affiliations
2222 NW Lovejoy St., Mob 1 Suite 411
Portland, OR, 97210
Phone (503) 413-5702
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
242 services
Medicare patients, 2024
74
Average age 72
Drug cost, 2024
$5.9M
979 prescriptions
Company payments, 2025
$98.07
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Catherine J Markin was code 99215 (office e&m - established), 52 times for 26 patients. In total Catherine J Markin billed 242 services in 33 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 52 | 26 | $147.64 | $7,677 |
| 99291 Critical Care E&M | Facility | 51 | 27 | $160.75 | $8,198 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 19 | $13.20 | $435 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 11 | $94.12 | $1,882 |
| 99214 Office E&M - Established | Office | 11 | 11 | $95.98 | $1,056 |
By year: 2022 $21K for 278 services; 2023 $22K for 204 services; 2024 $24K for 242 services.
Medicare prescription drug claims, 2024
In 2024, the drug Catherine J Markin prescribed most often to Medicare patients was Opsumit (Macitentan), with 137 prescriptions and refills. In total Catherine J Markin wrote 979 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 137 | 137 | 14 | $1.8M |
| Uptravi Selexipag | 112 | 112 | Under 11 | $2.5M |
| Potassium Chloride Generic | 84 | 148 | 19 | $1,870 |
| Furosemide Generic | 81 | 131 | 20 | $538 |
| Tadalafil Generic | 73 | 100 | 12 | $7,134 |
| Veletri Epoprostenol Sodium | 52 | 52 | Under 11 | $94K |
| Ambrisentan Generic | 41 | 41 | Under 11 | $91K |
| Sildenafil Citrate Generic | 35 | 55 | Under 11 | $7,809 |
| Xarelto Rivaroxaban | 31 | 37 | Under 11 | $19K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 31 | 37 | Under 11 | $931 |
| Winrevair Sotatercept-Csrk | 29 | 29 | Under 11 | $406K |
| Adempas Riociguat | 29 | 29 | Under 11 | $407K |
| Remodulin Treprostinil Sodium | 18 | 18 | Under 11 | $247K |
| Prednisone Generic | 17 | 28 | Under 11 | $62.8 |
| Famotidine Generic | 16 | 18 | Under 11 | $227 |
Brand drugs: 501 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Catherine J Markin $98.07 ($98.07 in general payments such as food, travel and fees) from 2 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $79.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.